Edgewise Therapeutics Inc (EWTX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $29.66
• Market Cap: $3.19B
• EPS: $-1.57
• 52-Week High: $31.82
• 52-Week Low: $10.60

Market Sentiment

Edgewise Therapeutics Inc currently has a Neutral sentiment score of 0.04.

About Edgewise Therapeutics Inc

Edgewise Therapeutics, Inc. is a biopharmaceutical company headquartered in Boulder, Colorado, dedicated to developing novel small molecule therapies for musculoskeletal diseases. Utilizing its proprietary platform, the company focuses on delivering precision medicine solutions that address significant unmet medical needs, particularly in muscle disorders and bone injuries. With a robust pipeline of transformative treatments, Edgewise Therapeutics is poised to advance the field of orthopedics...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Edgewise Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does EWTX pay dividends?

Edgewise Therapeutics Inc (EWTX) does not currently pay a regular dividend.

What is EWTX's market cap?

Edgewise Therapeutics Inc (EWTX) has a market capitalization of $3.19B with a current stock price of $29.66.